Search Results - "Tiersten, Amy D."

Long natural history of recurrent granulosa cell tumor of the ovary 23 years after initial diagnosis: a case report and review of the literature by Crew, Katherine D., Cohen, Michael H., Smith, Daniel H., Tiersten, Amy D., Feirt, Nikki M., Hershman, Dawn L.

“…Granulosa cell tumors (GCTs) of the ovary are rare, hormonally active neoplasms characterized by endocrine manifestations, an indolent course, and late…”
Get full text

Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma by Tiersten, Amy D, Selleck, Meredith J, Hershman, Dawn L, Smith, D, Resnik, Edward E, Troxel, Andrea B, Brafman, Lois B, Shriberg, Laureen

“…Objective. This trial investigated the safety and efficacy of paclitaxel and topotecan combination chemotherapy for patients with advanced cervical cancer…”
Get full text

A Case of Vasculitis in a Breast Cancer Patient Treated With T-DM1 by Bhardwaj, Aarti S, McLellan, Beth, Robinson, Maria R, Ghaw, Olivia, Lipsey, Lewis R, Tiersten, Amy D, Morris, Gloria J

Get full text

Phase II evaluation of neoadjuvant chemotherapy and debulking followed by intraperitoneal chemotherapy in women with stage III and IV epithelial ovarian, fallopian tube or primary peritoneal cancer: Southwest Oncology Group Study S0009 by Tiersten, Amy D, Liu, P.Y, Smith, Harriet O, Wilczynski, Sharon P, Robinson, William R, Markman, Maurie, Alberts, David S

“…Abstract Objective Intraperitoneal (IP) chemotherapy prolongs survival in optimally reduced ovarian cancer patients. For patients in whom optimal debulking…”
Get full text

A phase I trial of dose-dense (biweekly) carboplatin combined with paclitaxel and pegfilgrastim: A feasibility study in patients with untreated Stage III and IV ovarian, tubal or primary peritoneal cancer: A Gynecologic Oncology Group study by Tiersten, Amy D, Sill, Michael W, Knight, Danielle, Muggia, Franco, Garcia, Agustin A, Swensen, Ron, Warshal, David P, Mannel, Robert S, Fracasso, Paula M

“…Abstract Purpose Dose-dense regimens have been shown to improve outcome when given as adjuvant therapy to patients with breast cancer compared with their three…”
Get full text

Southwest Oncology Group Trial S9912: Intraperitoneal cisplatin and paclitaxel plus intravenous paclitaxel and pegylated liposomal doxorubicin as primary chemotherapy of small-volume residual stage III ovarian cancer by Smith, Harriet O, Moon, James, Wilczynski, Sharon P, Tiersten, Amy D, Hannigan, Edward V, Robinson, William R, Rivkin, Saul E, Anderson, Garnet L, Liu, P.Y, Markman, Maurie

“…Abstract Objective While primary cisplatin-based intraperitoneal chemotherapy has been shown to favorably impact survival in small-volume residual advanced…”
Get full text

Phase II Evaluation of Liposomal Doxorubicin with Docetaxel in Patients with Metastatic Breast Cancer by Fasano, Julie, Hershman, Dawn, Novik, Yelena, Levinson, Benjamin, Blozie, Kim, Tiersten, Amy D.

“…Background: Taxanes are effective in treating metastatic breast cancer. Liposomal doxorubicin (LD) is as effective as doxorubicin but less toxic. Patients and…”
Get full text

Chemotherapy resistance as a predictor of progression-free survival in ovarian cancer patients treated with neoadjuvant chemotherapy and surgical cytoreduction followed by intraperitoneal chemotherapy: a Southwest Oncology Group Study by Tiersten, Amy D, Moon, James, Smith, Harriet O, Wilczynski, Sharon P, Robinson, 3rd, William R, Markman, Maurie, Alberts, David S

“…In vitro testing of the activity of chemotherapeutic agents has been suggested as 1 method to optimally select drugs for patients with ovarian cancer. There…”
Get more information

A Phase II trial of docetaxel and estramustine in patients with refractory metastatic breast carcinoma by Tiersten, Amy D., Nelsen, Caron, Talbot, Susan, Vahdat, Linda, Fine, Robert, Troxel, Andrea, Brafman, Lois, Shriberg, Laureen, Antman, Karen, Petrylak, Daniel P.

“…BACKGROUND The similarity between the mechanism of action between docetaxel and estramustine generated the hypothesis of synergistic antimicrotubule effects…”
Get full text

Impact of the COVID-19 Pandemic on Cancer Care and Quality of Life for Patients With Breast and Gynecologic Malignancies: A Single-Center Survey-Based Study by Berger, Natalie F., Zimmerman, Brittney S., Seidman, Danielle, Cascetta, Krystal P., Moshier, Erin, Nezolosky, Michelle, Trlica, Kara, Ryncarz, Alisa, Keeton, Caitlin, Tiersten, Amy

“…This study evaluated the mental health and cancer treatment-related impact of the first wave of the COVID-19 pandemic on patients with breast and gynecologic…”
Get full text

Prospective Follow‐Up for Malignant Melanoma in Patients with Atypical‐Mole (Dysplastic‐Nevus) Syndrome by TIERSTEN, AMY D., GRIN, CARON M., KOPF, ALFRED W., GOTTLIEB, GEOFFREY J., BART, ROBERT S., RIGEL, DARRELL S., FRIEDMAN, ROBERT J., LEVENSTEIN, MARCIA J.

“…A total of 357 white patients who had melanocytic nevi that fulfilled the clinical criteria for the “classic” atypical‐mole (dysplastic‐nevus) syndrome (100 or…”
Get full text